期刊文献+

Angiopep-2修饰的纳米递药系统和纳米成像系统在胶质瘤诊疗中的应用 被引量:7

Application of Angiopep-2 Modified Nanoparticles in the Diagnosis and Treatment of Gliomas
下载PDF
导出
摘要 脑胶质瘤由于浸润性生长的特点以及存在血脑屏障(BBB),用于胶质瘤术前、术中定位诊断的成像效果不佳,常规的手术后放、化疗效果不佳,因此寻找可以穿越血脑屏障并靶向到肿瘤上的显像剂以及新的胶质瘤治疗方法尤为重要。近年来发现一种多肽Angiopep-2,能够通过高表达于血脑屏障和胶质瘤的低密度脂蛋白受体相关蛋白(LRP)介导,靶向血脑屏障和脑胶质瘤细胞,因此可以用Angiopep-2来修饰纳米递药和成像系统,以提高药物疗效和成像效果。本文综述了Angiopep-2的材料特点、血脑屏障的生理特征以及Angiopep-2修饰的纳米递药系统和纳米成像系统在胶质瘤诊疗中的应用进展。 The poor quality of images of glioma which are used preoperatively and intraoperatively is due to the invasive growth of brain gliomas and the blood-brain barrier(BBB), so brain gliomas has not got good therapeutic effect by subsequent radiotherapy and chemotherapy after surgery. Therefore, new imaging agents and therapeutic methods targeting both BBB and glioma are very imperative. Recent years, a new polypeptide named Angiopep-2, a ligand connected with low density lipoprotein receptor related proteins(LRP) which are over expressed on both BBB and glioma, is used to improve the quality of images during surgery and therapeutic effects of nanoparticle delivery system. In this review, the characteristics of Angiopep-2, physiological features of BBB and the applying of nanoparticle delivery system decorated with Angiopep-2 are presented.
出处 《中国医学计算机成像杂志》 CSCD 北大核心 2015年第5期413-418,共6页 Chinese Computed Medical Imaging
基金 国家自然科学基金No.30970805 81271632 上海市卫计委委级科研基金No.20114186 中国科学院上海硅酸盐研究所国家重点实验室开放基金No.SKL201303SIC~~
关键词 Angiopep-2 血脑屏障 胶质瘤 纳米探针 Angiopep-2 Blood Brain Barrier Glioma Nanoprobe
  • 相关文献

参考文献14

  • 1王逸麟,付爱玲.大分子药物的脑靶向给药研究进展[J].药学进展,2011,35(7):312-317. 被引量:2
  • 2熊志勇,王旋,张志平,谭松巍,赵洪洋,姜晓兵.Angiopep-2修饰纳米颗粒穿越血脑屏障的能力[J].华中科技大学学报(医学版),2014,43(3):304-306. 被引量:5
  • 3Gao X, Li C. Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier. Small, 2014,10:426-440.
  • 4Huang S, Li J, Han L, et al. Dual targeting effect of Angiopep-2- modified, DNA-loaded nanoparticles for glioma. Biomaterials, 2011,32:6832-6838.
  • 5Liu Y, Tu D, Zhu H, et al. Lanthanide-doped luminescent nanoprobes: controlled synthesis, optical spectroscopy, and bioapplications. Chem Soc Rev, 2013,42:6924-6958.
  • 6Ni D, Zhang J, Bu W, et al. Dual-targeting upconversion nanoprobes across the blood-brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma. ACS Nano, 2014,8:1231- 1242.
  • 7Yan H, Wang L, Wang J, et al. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano, 2012,6:410-420.
  • 8Sun X, Pang Z, Ye H, et al. Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome. Biomaterials, 2012,33:916-924.
  • 9Huang R, Ke W, Han L, et al. Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles. J Cereb Blood Flow Metab, 2009,29:1914-1923.
  • 10Sahay G, Alakhova D Y, Kabanov A V. Endocytosis of nanomedicines. J Control Release, 2010,145:182-195.

二级参考文献13

  • 1徐兰,郭增柱,张永振,熊成龙,Zhen F.Fu.狂犬病毒糖蛋白研究进展[J].中国人兽共患病学报,2006,22(9):876-879. 被引量:22
  • 2Cao G, Pei W, Ge H, et al. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuro- nal apeptosis[ J]. J Neurosci,2002,22( 13 ) :5423-5431.
  • 3Liu Y, Huang R, Han L, et al. Brain-targeting gene deli- very and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles [ J ]. Biomatenals ,2009,30(25 ) :4195-4202.
  • 4Brasnjevic I, Steinbusch H W, Schmitz C, et al. Delivery of peptide and protein drugs over the blood brain barrier[J]. Prog Neurobiol,2009,87(4) :212-251.
  • 5Ke W,Shao K,Huang R,et al. Gene delivery targeted to the brain using an angiopep-eonjugated polyethyleneglycol-modi- fled polyamidoamine dendrimer [J]. Biomaterials, 2009, 30 (36) :6976-6985.
  • 6Demeule M,Currie J C, Bertrand Y, et al. Involvement of the low-density lipoprotein receptor-related protein in the tran- scytosis of the brain delivery vector Angiopep-2[J]. J Neuro- chem, 2008,106 (4): 1534-1544.
  • 7Bickel U, Yoshikawa T, Pardridge W M. Deliery of peptides and proteins through the blood-brain barrier[J]. Adv Drug Deliv Rev,2001,46(1-3) :247-279.
  • 8Chen Y. Drug deliery across the blood-brain barrier[J]. Cur- rent Drug Deliery, 2004,1 (3): 361-376.
  • 9Li S D, Huang L. Pharmacokinetics and loiodistrihution of nanoparticles[J]. Mol Pharm, 2008,5 (4) : 496-504.
  • 10Gref R,Domb A, Quellec P, et al. The controlled intravenous deliery of drugs using PEG-coated stercally stabilized nano- spheres[J]. Adv Drug Deliv Rev, 1995,16(2/3) : 215-223.

共引文献5

同被引文献35

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部